Publicly funded health insurance programs across Australia, Canada, and the United States
Republicans are tapping Trump turnout power while shaping a cost‑of‑living policy platform, aiming to avoid a pure referendum on the president. Democrats counter with a 10‑bill progressive agenda and restructuring of district maps, signaling a high‑stakes clash ahead of midterms and 2028 considerations.
A string of articles examines how families manage dementia, long-term care and the financial burden that comes with aging parents. From the emotional toll to the economics of care, readers are guided through planning, support options and the realities of Medicare and Medicaid.
Weight-loss GLP-1 drugs are expanding beyond injections to pills in the US, UK and UAE. Major manufacturers report rising uptake and ongoing development, with Medicare and NHS access shaping pace and affordability. Private prescriptions and new formulations are widening access while competition accelerates.
Trust funds for Old-Age and Survivors Insurance and Medicare face earlier depletion than previously forecast. PWBM projects depletion by 2033 for OASI and 2034 for combined funds, while the official trustees warn longer-term pressures. Lawmakers face urgent choices on taxes, benefits, and program integrity as costs rise for aging Americans.
A federal crackdown targets healthcare fraud across the United States. More than 450 defendants, including doctors, nurses and clinic owners, are charged in schemes that falsified records, billed for unrendered or unnecessary care, and laundered funds. Several defendants have faced seizures and high-value assets, with charges spanning Medicare and TRICARE programs.
Germany’s pension commission has proposed a fund-based pillar, with mandatory employer and employee contributions invested in markets. It also recommends gradually increasing retirement age to about 70 by the early 2090s and scrapping early retirement options, with swift parliamentary action anticipated.
Whey protein, once a byproduct of cheese making, has become a hot commodity as demand for protein grows amid weight‑loss drug uptake and broader consumer interest. Inventories are falling and prices have risen, while producers race to expand capacity to meet rising demand.
The ACA marketplace faces double-digit premium hikes in 2027 as costs rise and enhanced subsidies expire. Enrollment has fallen in several states, driven by higher costs and ongoing regulatory changes, with debates over whether subsidies should be renewed amid affordability concerns ahead of the 2026 midterms.
France 24 reports that DR Congo has advanced to the World Cup knockout stage for the first time, following a 3-1 win over Uzbekistan. England tops Group L after a win over Panama; Belgium faces Senegal; US advances to the Round of 16 with favorable simulations.
Tom Kean Jr. has explained that his four-month absence from Congress was due to inpatient treatment for depression. He says he is healthier and ready to resume his duties, while Republicans argue for transparency and Democrats scrutinize the absence in a closely watched New Jersey district ahead of the November election.
A new weight‑loss pill version of semaglutide has launched in the UK for private prescriptions, offering an alternative to injections. The tablet requires strict dosing and a fasting routine and is not yet NHS‑funded. Several outlets warn about counterfeit pills as access broadens.
The 340B program, which lets hospitals buy discounted outpatient drugs for low-income patients, is facing a new CMS rule changing reimbursement formulas to reduce payments by about 40%. The move aims to lower patient costs but could shrink hospital revenues and affect services and jobs. The rule follows an executive order in 2025 and reflects ongoing political battles between hospitals and the pharmaceutical industry.
The Guardian reports on forced adoptions and the government’s formal apology. Survivors say the apology is a milestone but demand tangible support, with personal stories of loss and struggle highlighted. The coverage includes reactions from campaigners and experts.
A wave of earnings reports and mixed inflation signals have kept markets cautious. Major corporates report results this week as investors weigh outlooks against rising costs and central-bank expectations.
The Social Security retirement fund is projected to exhaust its reserves by 2032. A bipartisan push seeks solutions to extend solvency, with proposals including PROMISE and Social Security 2100 Act. COLA trends show adjustments for 2027 and beyond amid inflation.